External evaluation of gait and functional changes after a single-session multiple myofibrotenotomy in school-aged children with spastic diplegia;Evaluación externa de los cambios funcionales y la marcha tras una sesión de miofibrotomía múltiple en escolares con diplejía espástica

Revista de Neurologia

Volumn 58, Issue 6, 2014, Pages 247-254

  Gómez Andrés, David ^a   Pulido Valdeolivas, Irene ^a   Martín Gonzalo, Juan Andrés ^a   López López, Javier ^b   Martínez Caballero, Ignacio ^c   Gómez Barrena, Enrique ^d,e   Rausell, Estrella ^a,f  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d Policlínica de Especialidades CMH   (Spain)

^e Servicio de Cirugía Ortopédica y Traumatología Hospital Virgen del Mar   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cerebral palsy; Gait; Surgery; Ulzibat; Walking

Indexed keywords

ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL EVALUATION; FUNCTIONAL DISEASE; FUNCTIONAL MOBILITY SCALE; GAIT; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; GROSS MOTOR FUNCTION MEASURE; HUMAN; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; MULTIPLE MYOFIBEROTOMY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SURGICAL TECHNIQUE; FEMALE; MALE; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SKELETAL MUSCLE;

CEREBRAL PALSY; CHILD; FEMALE; GAIT; HUMANS; MALE; MUSCLE, SKELETAL; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE;

EID: 84896449776     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5806.2013427     Document Type: Article

References (27)

1. Platt MJ, Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et al. Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 2007; 369: 43-50.
2. Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, Van Campenhout A, et al. The updated European Consensus 2009 on the use of botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2010; 14: 45-66.
3. Deon LL, Gaebler-Spira D. Assessment and treatment of movement disorders in children with cerebral palsy. Orthop Clin North Am 2010; 41: 507-17.
4. Oppenheim WL. Complementary and alternative methods in cerebral palsy. Dev Med Child Neurol 2009; 51 (Suppl 4): S122-9.
5. Rosenbaum P. Controversial treatment of spasticity: exploring alternative therapies for motor function in children with cerebral palsy. J Child Neurol 2003; 18 (Suppl 1): S89-94.
6. Liptak GS. Complementary and alternative therapies for cerebral palsy. Ment Retard Dev Disabil Res Rev 2005; 11: 156-63.
7. Weisleder P. Unethical prescriptions: alternative therapies for children with cerebral palsy. Clin Pediatr (Phila) 2010; 49: 7-11.
8. Ulzibat V, Shishov S. Operative treatment of primary fibromyalgia (myofibrillosis). Complement Ther Med 1995; 3: 72-4.
9. En Rusia se hizo el milagro. URL: http://es.wikipedia.org/wiki/ulzibat. [02.10.2012].
10. Econ Medical Services. URL: http://www.serviciosmedicosecon.com/eng/index.html. [02.12.2012].
11. Gage JR. The identification and treatment of gait problems in cerebral palsy. 2 ed. London: Mac Keith Press; 2009.
12. Abel MF, Damiano DL, Pannunzio M, Bush J. Muscle-tendon surgery in diplegic cerebral palsy: functional and mechanical changes. J Pediatr Orthop 1999; 19: 366-75.
13. Kondo I, Hosokawa K, Iwata M, Oda A, Nomura T, Ikeda K, et al. Effectiveness of selective muscle-release surgery for children with cerebral palsy: longitudinal and stratified analysis. Dev Med Child Neurol 2004; 46: 540-7.
14. Mitsiokapa EA, Mavrogenis AF, Skouteli H, Vrettos SG, Tzanos G, Kanellopoulos AD, et al. Selective percutaneous myofascial lengthening of the lower extremities in children with spastic cerebral palsy. Clin Pediatr Med Surg 2010; 27: 335-43.
15. Institut of Clinical Rehabilitology. Regional patners. URL: http://ulzibat.ru/en/partners/. [02.12.2012].
16. Wood E, Rosenbaum P. The gross motor function classification system for cerebral palsy: a study of reliability and stability over time. Dev Med Child Neurol 2000; 42: 292-6.
17. Avery LM, Russell DJ, Raina PS, Walter SD, Rosenbaum PL. Rasch analysis of the Gross Motor Function Measure: validating the assumptions of the Rasch model to create an intervallevel measure. Arch Phys Med Rehabil 2003; 84: 697-705.
18. Graham HK, Harvey A, Rodda J, Nattrass GR, Pirpiris M. The Functional Mobility Scale (FMS). J Pediatr Orthop 2004; 24: 514-20.
19. Schutte LM, Narayanan U, Stout JL, Selber P, Gage JR, Schwartz MH. An index for quantifying deviations from normal gait. Gait Posture 2000; 11: 25-31.
20. Pulido-Valdeolivas I, Gómez-Andrés D, Martín-Gonzalo JA, López-López J, Gómez-Barrena E, Sánchez-Hernández JJ, et al. Gait parameters in a reference sample of healthy Spanish schoolchildren: multivariate descriptive statistics and asymmetries observed in left and right cycles. Neurologia 2013; 28: 145-52.
21. Cretual A, Bervet K, Ballaz L. Gillette Gait Index in adults. Gait Posture 2010; 32: 307-10.
22. Gray L, Ng H, Bartlett D. The gross motor function classification system: an update on impact and clinical utility. Pediatr Phys Ther 2010; 22: 315-20.
23. Russell DJ, Avery LM, Walter SD, Hanna SE, Bartlett DJ, Rosenbaum PL, et al. Development and validation of item sets to improve efficiency of administration of the 66-item Gross Motor Function Measure in children with cerebral palsy. Dev Med Child Neurol 2010; 52: e48-54.
24. Harvey AR, Morris ME, Graham HK, Wolfe R, Baker R. Reliability of the functional mobility scale for children with cerebral palsy. Phys Occup Ther Pediatr 2010; 30: 139-49.
25. Tulchin K, Campbell S, Browne R, Orendurff M. Effect of sample size and reduced number of principle components on the Gillette Gait Index. Gait Posture 2009; 29: 526-9.
26. Lynn AK, Turner M, Chambers HG. Surgical management of spasticity in persons with cerebral palsy. PM R 2009; 1: 834-8.
27. Unlu E, Cevikol A, Bal B, Gonen E, Celik O, Kose G. Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study. Clinics (Sao Paulo) 2010; 65: 613-9.